Clinical Trial

Validation of Self Testing Using the INSTI Multiplex HIV1/2 Syphilis Antibody Test

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to validate the percent agreement of the INSTI Multiplex Human Immunodeficiency (HIV) 1/2 syphilis antibody (Ab) test (INSTI POCT) when used as a self-test by patients compared to conventional serologic testing.
Trial Details
NCT Number NCT06953024
Lead Sponsor Nova Scotia Health Authority
Conditions Hiv, Syphilis
Enrollment 120 participants
Start Date 2025-06
Primary Completion 2026-10 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-05-01